Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Down again

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Sep 09, 2022 12:15pm

136 Views

Post# 34952389

Down again

Down again... maybe they put out a PR at 4:30 on a friday... we are happy to announce at bought deal with Cannaccord as the lead.... thus the 3$ target bump.... just speculating lol... but still possible... before any Th1902 news and top it off with some additional insider selling.. who knows with them... they do have a tendency to scr w-up in every way possible in the past.

<< Previous

Bullboard Posts

Next >>

Bombardier shows off Challenger 3500 for customers in Italy